Citation Impact
Citing Papers
Complementary and alternative medicine in cardiovascular disease: a review of biologically based approaches
2004
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Biological And Health Effects Of Exposure To Kerosene-Based Jet Fuels And Performance Additives
2003
Aircraft engine exhaust emissions and other airport-related contributions to ambient air pollution: A review
2014 Standout
Policosanol: Clinical pharmacology and therapeutic significance of a new lipid-lowering agent
2002
Policosanol safely down-regulates HMG-CoA reductase – potential as a component of the Esselstyn regimen
2002
Oral Administration of Policosanol Inhibits In Vitro Copper Ion-Induced Rat Lipoprotein Peroxidation
1999
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Antiplatelet effects of policosanol (20 and 40 mg/day) in healthy volunteers and dyslipidaemic patients
2002
Wheat germ policosanol failed to lower plasma cholesterol in subjects with normal to mildly elevated cholesterol concentrations
2004
Immunomodulatory and therapeutic properties of the Nigella sativa L. seed
2005 Standout
Sorghum phytochemicals and their potential impact on human health
2004 Standout
New hypotheses for the health-protective mechanisms of whole-grain cereals: what is beyond fibre?
2010 Standout
Octacosanol in human health
2003
A comparative study of policosanol vs lovastatin on intimal thickening in rabbit cuffed carotid artery
2001
Effects of statins on stroke prevention in patients with and without coronary heart disease: A meta-analysis of randomized controlled trials
2004
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Effect of genetic variation on phenolic acid and policosanol contents of Pegaso wheat lines
2007
Pressurised solvent extraction of policosanol from wheat straw, germ and bran
2009
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Nutritional Significance and Metabolism of Very Long Chain Fatty Alcohols and Acids from Dietary Waxes
2004
Policosanol contents of beeswax, sugar cane and wheat extracts
2005
Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
2019 Standout
Novel food and non-food uses for sorghum and millets
2006 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Effect of policosanol on platelet aggregation and serum levels of arachidonic acid metabolites in healthy volunteers
1998
Role of Policosanols in the Prevention and Treatment of Cardiovascular Disease
2003
Cholesterol-lowering effect of policosanol on rabbits with hypercholesterolaemia induced by a wheat starch-casein diet
1997
Effects of policosanol in hypertensive patients with type II hypercholesterolemia
1996
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
A review on heavy metal pollution, toxicity and remedial measures: Current trends and future perspectives
2019 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Works of J Illnait being referenced
Effect of policosanol on serum lipids and lipoproteins in healthy volunteers
1992
Effects of Policosanol on Patients with Ischemic Stroke: A Pilot Open Study
2006
Effects of D-002 on Lipid Peroxidation in Older Subjects
2001
Effects of policosanol on postmenopausal women with type II hypercholesterolemia
2000
Effects of Policosanol in Older Patients With Type II Hypercholesterolemia and High Coronary Risk
2001
Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors
1999
Effect of successive dose increases of policosanol on the lipid profile and tolerability of treatment
1993
Effects of Policosanol on Older Patients with Hypertension and Type II Hypercholesterolaemia
2002
A two-year study on the efficacy and tolerability of policosanol in patients with type II hyperlipoproteinaemia.
1995
Comparative study of the efficacy and tolerability of policosanol and lovastatin in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus.
1999
Effects of policosanol in elderly hypercholesterolemic patients
1993
Comparison of the efficacy, safety and tolerability of original policosanol versus other mixtures of higher aliphatic primary alcohols in patients with type II hypercholesterolemia.
2002
Changes in the aorta of guinea pigs exposed to kerosene.
1987
Efficacy and safety of policosanol in patients with primary hypercholesterolemia
1992
Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study.
2001
Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients.
1999
Pharmacoepidemiologic study of policosanol
1999
Comparison of the Efficacy and Tolerability of Policosanol with Atorvastatin in Elderly Patients with Type II Hypercholesterolaemia
2003
Effects of successive dose increases of policosanol on the lipid profile of patients with type II hypercholesterolaemia and tolerability to treatment.
1994
Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients
2000